Assignee
EXELA PHARMA SCIENCES LLC
US·23 granted patents·2 pending applications·139 citations·filing 2019–2025
Top patents by PatentIndex Score
25 records- 0198US10478453B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Nov 19, 2019·22 cites·22 claims
- 0297US11510942B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·9 cites·34 claims
- 0397US11510941B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2021·Granted Nov 29, 2022·11 cites·17 claims
- 0497US10933089B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 2, 2021·13 cites·27 claims
- 0597US10918662B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 16, 2021·13 cites·29 claims
- 0697US10912795B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 9, 2021·13 cites·29 claims
- 0797US10905713B2Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·27 claims
- 0897US10905714B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Feb 2, 2021·13 cites·29 claims
- 0997US10653719B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2020·Granted May 19, 2020·14 cites·27 claims
- 1097US10583155B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2019·Granted Mar 10, 2020·15 cites·30 claims
- 1193US12569513B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Mar 10, 2026·0 cites·28 claims
- 1293US11266621B1Methocarbamol composition and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Mar 8, 2022·2 cites·21 claims
- 1392US12186338B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Jan 7, 2025·0 cites·21 claims
- 1492US12171781B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2024·Granted Dec 24, 2024·0 cites·30 claims
- 1591US11969439B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Apr 30, 2024·0 cites·30 claims
- 1689US11826383B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2023·Granted Nov 28, 2023·0 cites·30 claims
- 1787US11648262B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 1887US11642370B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted May 9, 2023·0 cites·30 claims
- 1986US11684636B1Stable, highly pure l-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 27, 2023·0 cites·30 claims
- 2085US11679125B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 20, 2023·0 cites·27 claims
- 2184US11672824B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2022·Granted Jun 13, 2023·0 cites·30 claims
- 2281US11723978B2Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2020·Granted Aug 15, 2023·1 cites·18 claims
- 2381US2025319189A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2024·Application pending·0 cites
- 2478US2024181064A1Ganciclovir compositions and related methodsEXELA PHARMA SCIENCES LLC·Filed 2023·Application pending·0 cites
- 2577US12569514B1Stable, highly pure L-cysteine compositions for injection and methods of useEXELA PHARMA SCIENCES LLC·Filed 2025·Granted Mar 10, 2026·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when EXELA PHARMA SCIENCES LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →